WBEZ brings you fact-based news and information.
Sign up for our newsletters
to stay up to date on the stories that matter.
The FDA approved Johnson & Johnson’s one-dose COVID-19 vaccine Saturday, setting off a scramble to distribute the shots and adding a dimension to the ongoing debate about how to ensure vaccination rolls out equitably in Chicago, Illinois and the nation.
Reset talks to a reporter and a local healthcare leader about whether the newly-greenlit J&J vaccine — as well as a new mass vaccination site at the United Center — could help vulnerable populations in the city get inoculated more quickly and more equitably.
GUESTS: Stephanie Goldberg, Crain’s Chicago Business health reporterDonna Thompson, CEO of ACCESS Community Health Network